Generic launch command center

Win more Indian generic programs with faster CMC decisions, cleaner evidence, and sharper launch economics.

BayesPK Generics gives portfolio, formulation, analytical, QA, manufacturing, and regulatory teams one operating layer for selecting products, designing Q1/Q2-ready formulations, controlling batch economics, preparing ANDA/eCTD evidence, and managing lifecycle obligations across India, US, EU, and tender-driven markets.

Open Formulation Hub Open Regulatory Control Open Module Cockpit
01Pick profitable moleculesCompare patent timing, competition, tenders, margin pressure, and evidence burden before committing R&D spend.
02Design CMC with proofConnect API properties, excipients, process risk, dissolution, validation, stability, and filing rationale.
03Protect Indian cost advantageTrack supplier options, batch cost, yield loss, scale-up sensitivity, and tender pricing scenarios together.
04Move faster to submissionPrepare Module 3, eCTD, BE, QMS, stability, PV, and post-approval evidence in one connected workflow.
API and QTPP Market opportunity Tender pricing Preformulation Analytical methods ICH Q2 validation Supplier sourcing Formulation hub Excipient strategy QbD safe space Cost control Scale-up risk Pilot transfer BMR records QMS + CAPA ICH stability PV + PSUR FaSSIF/FeSSIF Dissolution f2 BE readiness Module 3 + eCTD Deadline calendar Post-approval
Built for Indian generic companies

Operate from molecule selection to regulated-market launch without losing the economics.

Indian manufacturers compete on speed, compliance discipline, procurement leverage, and reliable scale-up. This command view keeps the commercial and technical evidence moving together.

PortfolioPatent, competition, tender, and margin triagePrioritize molecules where Indian cost structure and evidence readiness can create a defensible launch path.
CMCQTPP, Q1/Q2, dissolution, and scale-up fitTurn preformulation and excipient choices into a coherent development and manufacturing story.
QualityValidation, BMR, QMS, stability, and CAPA controlKeep method validation, batch records, deviations, stability commitments, and audit readiness visible.
RegulatoryANDA, eCTD, DCGI, FDA, EMA, and lifecycle datesTrack dossier content, regulatory deadlines, annual reports, and post-approval commitments in one place.
ManufacturingPilot transfer, yield, equipment, and site riskFlag batch failure modes early enough for formulation, process, and procurement teams to respond.
CommercialSupplier leverage, tender response, and cost pressureConnect API/excipient sourcing, price pressure, and batch economics before bid or launch decisions.
Product-to-approval workflow

From reference product strategy to commercial batch readiness.

A disciplined path for teams that need product decisions to survive cost review, scale-up, and regulatory scrutiny.

1

Target

Define QTPP, RLD expectations, dose strength, route, release goals, and evidence burden.

2

Design

Generate formulation options aligned with API properties, Q1/Q2 intent, and manufacturability.

3

Optimize

Balance material cost, dissolution behavior, process risk, and batch economics.

4

Submit

Connect scale-up rationale, f2 similarity, BE results, and CMC narrative into review-ready evidence.

India-to-global readiness

A practical operating model for Hyderabad, Ahmedabad, Mumbai, Bengaluru, Pune, and Vizag generic teams.

The suite is shaped around the work Indian companies do every day: portfolio selection, API sourcing, cost pressure, plant transfer, quality documentation, regulated-market filing, and lifecycle maintenance.

Tender and institutional businessModel bid strategy, price pressure, proposal readiness, and cost-to-serve before committing supply.
API and excipient leverageCompare supplier risk, DMF status, quote economics, and cost per tablet for procurement decisions.
Audit-ready quality systemConnect BMRs, deviations, CAPA, validation, stability, and post-approval commitments before inspection pressure arrives.
Export-market dossier disciplineKeep ANDA Module 3, eCTD outputs, BE evidence, dissolution rationale, and regulatory calendars aligned.
Operating modules

Open the exact workspace your team needs today.

Search or filter by operating lane: portfolio, CMC, analytical, manufacturing, quality, regulatory, or lifecycle. Each module opens directly into a working tool.

Formulation anchor Generic Formulation Hub Start here when QTPP, API properties, target dissolution, and manufacturability need to become an actionable CMC plan. Open hub ANDA intelligence Source watch, Module 3, deficiency response, and packet export. Run FDA/PSG/Orange Book source watch, CMC narrative composition, impurity and supplier risk, launch readiness, and decision packet export. Open board
Model-informed
Model-Informed Generics Copilot Evidence-guided generic development support for formulation questions, IID checks, patent context, and launch readiness.
Reverse
RLD Reverse Engineering Paragraph IV, innovator formulation inference, patent timing, and global regulator intelligence for generic entry strategy.
Portfolio
Market Opportunity Analyzer Generic market size, patent timing, competitor load, ROI, and portfolio prioritization.
Tender
Tender & Pricing Intelligence Government tenders, competitive pricing, bid strategy, pricing trends, and proposal support.
Preformulation
Pre-formulation Suite API characterization, compatibility studies, BCS classification, and dose proportionality checks.
Analytical
Analytical Method Development HPLC method development, dissolution method design, acceptance checks, and ICH Q2 support.
Validation
Method Validation ICH Q2(R2) validation, HPLC/GC procedures, LOD/LOQ calculation, parameters, and reports.
Sourcing
API & Excipient Sourcing Supplier intelligence, DMF status, price comparison, quote building, and cost-per-tablet estimates.
Formulation
Excipient Recommender API property review, excipient class selection, prototype composition, and performance targets.
Economics
Formulation Cost Optimizer Material cost breakdown, alternative excipient economics, batch savings, and cost-performance tradeoffs.
QbD
QbD Safe Space Dissolution design-space ranges, parameter sensitivity, risk assessment, and ICH Q8/Q9/Q10 support.
Manufacturing
Scale-Up Risk Predictor Commercial transfer risk, process sensitivity, equipment scale, yield impact, and mitigation priorities.
Pilot
Pilot Batch & Scale-up Scale-up prediction, pilot parameters, technology transfer planning, and batch failure analysis.
BMR
BMR Generator GMP batch manufacturing records, batch status updates, summaries, and audit timelines.
QMS
QMS Dashboard Quality metrics, deviation reporting, investigations, CAPA, audit scheduling, and deviation reports.
Stability
Stability Tracker ICH stability studies, storage conditions, OOS detection, shelf-life prediction, and trend reports.
Safety
Pharmacovigilance Adverse event tracking, seriousness review, PV dashboard metrics, ICH E2B support, and PSUR generation.
Dissolution
f2 Similarity Calculator Reference-test profile comparison, f2 scoring, curve visualization, and regulatory interpretation.
Biorelevant
Biorelevant Dissolution FaSSIF/FeSSIF profile prediction, fasted-fed comparison, and food-effect risk interpretation.
Bioequivalence
BE Testing Geometric mean ratios, 90% confidence intervals, crossover study review, and BE decision context.
Regulatory
Regulatory Control Tower Coordinate PSG source posture, Program OS evidence, Module 3, eCTD QC, correspondence triage, patent timing, and lifecycle handoffs.
Submission
Regulatory Filing Suite Generate ANDA module maps, evidence inventory, eCTD plans, readiness, deficiency risk, questions, response strategy, and package reports.
Calendar
Regulatory Calendar FDA, EMA, DCGI, and MHRA deadline tracking, alerts, reminders, and regulatory deadline calculators.
Lifecycle
Post-Approval Management Annual reports, change control, lifecycle milestones, and compliance scoring after approval.
Scale-up readiness

Bring manufacturing risk into formulation decisions early.

Generic profitability depends on repeatable commercial batches, not only a promising lab-scale formula.

Blend and flowConnect particle size, flowability, lubricants, and blend sensitivity to scale-up risk.
CompressionFlag tabletability, hardness, friability, and compression window concerns before transfer.
Coating and releaseWatch coating, disintegration, and dissolution risks that can drift between scales.
Yield economicsTranslate manufacturability risk into cost, batch loss, and launch-readiness consequences.
Predict Scale-Up Risk Review Cost Impact
Evidence path

A cleaner story from product design to eCTD-ready ANDA review.

The strongest generic programs treat composition, cost, scale-up, stability, pharmacovigilance, dissolution, BE, Module 3 content, eCTD package assembly, deadline tracking, and post-approval obligations as one connected evidence system.

1QTPP and RLDDefine target attributes, route, strength, release goal, and reference expectations.
2Composition and QbDBuild a formula rationale and safe-space ranges that match API behavior and product performance.
3Scale and compareControl cost, design-space risk, and transfer risk while resolving f2 and biorelevant dissolution gaps.
4Control, file, and maintainCarry PSG/source posture, BE, dissolution, stability, PV reporting, formulation, process evidence, Module 3 sections, eCTD backbone, regulatory dates, and post-approval commitments into one lifecycle package.